De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

KPJ Healthcare Berhad Beheer

Beheer criteriumcontroles 2/4

De CEO KPJ Healthcare Berhad's is Keat Chin, benoemd in Sep2023, heeft een ambtstermijn van 1.08 jaar. De totale jaarlijkse vergoeding van { bedraagt MYR 653.20K, bestaande uit 90.6% salaris en 9.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.014% van de aandelen van het bedrijf, ter waarde MYR 1.27M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.4 jaar en 3.9 jaar.

Belangrijke informatie

Keat Chin

Algemeen directeur

RM 653.2k

Totale compensatie

Percentage CEO-salaris	90.6%
Dienstverband CEO	1.1yrs
Eigendom CEO	0.01%
Management gemiddelde ambtstermijn	1.4yrs
Gemiddelde ambtstermijn bestuur	3.9yrs

Recente managementupdates

Recent updates

Is There An Opportunity With KPJ Healthcare Berhad's (KLSE:KPJ) 33% Undervaluation?

Jun 24

KPJ Healthcare Berhad's (KLSE:KPJ) Dividend Will Be MYR0.01

Jun 02

Here's Why KPJ Healthcare Berhad (KLSE:KPJ) Has Caught The Eye Of Investors

Mar 25

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

Mar 11

KPJ Healthcare Berhad's (KLSE:KPJ) Shares May Have Run Too Fast Too Soon

Feb 14

Is KPJ Healthcare Berhad (KLSE:KPJ) Using Too Much Debt?

Jan 23

Returns At KPJ Healthcare Berhad (KLSE:KPJ) Appear To Be Weighed Down

Jan 09

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 31% Above Its Share Price

Jun 06

These 4 Measures Indicate That KPJ Healthcare Berhad (KLSE:KPJ) Is Using Debt Reasonably Well

May 03

KPJ Healthcare Berhad (KLSE:KPJ) Has More To Do To Multiply In Value Going Forward

Mar 07

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 20

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 26% Above Its Share Price

Jan 31

KPJ Healthcare Berhad (KLSE:KPJ) Is Increasing Its Dividend To MYR0.0055

Sep 15

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 01

Capital Allocation Trends At KPJ Healthcare Berhad (KLSE:KPJ) Aren't Ideal

Aug 11

The Consensus EPS Estimates For KPJ Healthcare Berhad (KLSE:KPJ) Just Fell Dramatically

May 30

Does KPJ Healthcare Berhad (KLSE:KPJ) Have A Place In Your Dividend Stock Portfolio?

Apr 09

Analyse CEO-vergoeding

Hoe is Keat Chin's beloning veranderd ten opzichte van KPJ Healthcare Berhad's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	RM 304m
Mar 31 2024	n/a	n/a	RM 303m
Dec 31 2023	RM 653k	RM 592k	RM 281m

Compensatie versus markt: De totale vergoeding ($USD 156.77K ) Keat } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de MY markt ($USD 602.05K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Keat te vergelijken met de prestaties van het bedrijf.

CEO

Keat Chin (50 yo)

1.1yrs

Tenure

RM 653,200

Compensatie

Mr. Keat Chyuan Chin serves as President, Managing Director & Director of KPJ Healthcare Berhad since September 01, 2023. He serves as Vice President of Ethicon South East Asia since July 2022 and Board of...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Keat Chin	President	1.1yrs	RM 653.20k	0.014% MYR 1.3m
Mohd Khairul Bin Mohammed Shamsudin	Chief Financial Officer	less than a year	geen gegevens	geen gegevens
Sharizul Bin Baseri	Head of Group Risk & Compliance	2.2yrs	geen gegevens	geen gegevens
Syed Iskandar Bin Syed Abu Bakar	Head of Legal & Secretarial Services	1.7yrs	geen gegevens	geen gegevens
Natalie Ariffin	Head of Group Strategic Communications	1.1yrs	geen gegevens	geen gegevens
Sherene Azli	Chief Marketing Officer	less than a year	geen gegevens	geen gegevens
Norhamijah Hanafiah	Chief Human Resource Officer	1.4yrs	geen gegevens	geen gegevens
Mohd Farid Bin Salim	Chief Operating Officer of Hospital Operations	no data	geen gegevens	geen gegevens
Zabidi Razak	Regional Chief Executive Officer of East Coast & Northern Region	less than a year	geen gegevens	geen gegevens
Asmadi Mohd Bakri	Regional CEO of Group Operations Services (East Malaysia Region)	1.9yrs	geen gegevens	geen gegevens
Mohd Bin Abdullah	Regional CEO of Group Operations Services (Southern Region)	1.9yrs	geen gegevens	geen gegevens
Nik Fawaz Bin Nik Aziz	Chief Operating Officer Group Allied & Retail Health Operations	2.2yrs	geen gegevens	geen gegevens

1.4yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van KPJ wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.4 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Keat Chin	President	1.1yrs	RM 653.20k	0.014% MYR 1.3m
Hussein bin Awang	Medical Director of KPJ Tawakkal Health Centre & Member of Medical Advisory Committee	no data	RM 40.70k	geen gegevens
Gunavathy Kalee	GM of Clinical Services & Member of Medical Advisory Committee	no data	geen gegevens	geen gegevens
Shahrudin bin Mohd Dun	Medical Director of KPJ Selangor Specialist Hospital & Member of Medical Advisory Committee	no data	geen gegevens	geen gegevens
Fadzli Abdullah	Medical Director of KPJ Ipoh Specialist Hospital & Member of Medical Advisory Committee	no data	geen gegevens	geen gegevens
Azizi Bin Omar	Non Independent Non-Executive Director & Member of Medical Advisory Committee	8.7yrs	RM 563.90k	0.0076% MYR 692.9k
Mohd bin Ahmad	Member of Medical Advisory Committee	no data	geen gegevens	geen gegevens
Hisham Bin Zainal Mokhtar	Independent Non Executive Director	3.3yrs	RM 307.40k	geen gegevens
Mohamed Mohamed Abdulla	Independent Non-Executive Director	4.5yrs	RM 274.00k	geen gegevens
Mohd. Redza Bin Abdul Wahid	Senior Independent Non-Executive Director	4.4yrs	RM 391.50k	geen gegevens
Zaki Bin Mohamad Zaher	Chairman of Medical Advisory Committee	no data	RM 405.00k	geen gegevens
Ismail Bin Bakar	Non Independent and Non Executive Chairman	less than a year	geen gegevens	geen gegevens

3.9yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van KPJ wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.9 jaar).

KPJ Healthcare Berhad Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

KPJ Healthcare Berhad Appoints Encik Mohd Khairul Izzad Bin Mohammed Shamsudin as Chief Financial Officer, Effective June 10, 2024

KPJ Healthcare Berhad, Annual General Meeting, Jun 26, 2024

KPJ Healthcare Berhad Announces Resignation of Md Arif Bin Mahmood as Non Independent and Non Executive Chairman, Effective April 1, 2024

KPJ Healthcare Berhad Announces Appointment of Keh Ching Tyng as Joint Secretary

Kpj Healthcare Berhad Announces Appointment of Mr. Chin Keat Chyuan as President, Effective 1 September 2023

KPJ Healthcare Berhad Appoints Encik Hisham Bin Zainal Mokhtar as Independent and Non Executive Member of Risk Committee

Recent updates

KPJ Healthcare Berhad (KLSE:KPJ) Has Affirmed Its Dividend Of MYR0.01

Second quarter dividend of RM0.01 announced

KPJ Healthcare Berhad to Report Q2, 2024 Results on Aug 28, 2024

Second quarter 2024 earnings: Revenues exceed analyst expectations

Returns Are Gaining Momentum At KPJ Healthcare Berhad (KLSE:KPJ)

Do KPJ Healthcare Berhad's (KLSE:KPJ) Earnings Warrant Your Attention?

Is There An Opportunity With KPJ Healthcare Berhad's (KLSE:KPJ) 33% Undervaluation?

Price target increased by 7.4% to RM1.93

KPJ Healthcare Berhad Appoints Encik Mohd Khairul Izzad Bin Mohammed Shamsudin as Chief Financial Officer, Effective June 10, 2024

KPJ Healthcare Berhad's (KLSE:KPJ) Dividend Will Be MYR0.01

First quarter dividend of RM0.01 announced

First quarter 2024 earnings: EPS misses analyst expectations

KPJ Healthcare Berhad, Annual General Meeting, Jun 26, 2024

Here's Why KPJ Healthcare Berhad (KLSE:KPJ) Has Caught The Eye Of Investors

KPJ Healthcare Berhad Announces Resignation of Md Arif Bin Mahmood as Non Independent and Non Executive Chairman, Effective April 1, 2024

KPJ Healthcare Berhad (KLSE:KPJ) Shares Could Be 37% Below Their Intrinsic Value Estimate

Price target increased by 8.3% to RM1.72

Full year 2023 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad's (KLSE:KPJ) Shares May Have Run Too Fast Too Soon

Is KPJ Healthcare Berhad (KLSE:KPJ) Using Too Much Debt?

Returns At KPJ Healthcare Berhad (KLSE:KPJ) Appear To Be Weighed Down

Upcoming dividend of RM0.013 per share at 3.0% yield

Price target increased by 8.6% to RM1.48

KPJ Healthcare Berhad to Report Q3, 2023 Results on Nov 28, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Special Dividend for the Financial Year Ending 31 December 2023

KPJ Healthcare Berhad Announces Appointment of Keh Ching Tyng as Joint Secretary

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Kpj Healthcare Berhad Announces Appointment of Mr. Chin Keat Chyuan as President, Effective 1 September 2023

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 31% Above Its Share Price

KPJ Healthcare Berhad Declares Interim Dividend for the Year Ended December 31, 2023, Payable on July 4, 2023

First quarter 2023 earnings: EPS exceeds analyst expectations

Now 22% undervalued

These 4 Measures Indicate That KPJ Healthcare Berhad (KLSE:KPJ) Is Using Debt Reasonably Well

Full year 2022 earnings released: EPS: RM0.04 (vs RM0.013 in FY 2021)

Now 23% undervalued

Now 22% undervalued

Now 21% undervalued

KPJ Healthcare Berhad (KLSE:KPJ) Has More To Do To Multiply In Value Going Forward

Consensus EPS estimates increase by 25%

Price target increased by 8.7% to RM1.23

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2022 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Financial Year End December 31, 2023, Payable on April 14, 2023

Now 21% undervalued

KPJ Healthcare Berhad's (KLSE:KPJ) Intrinsic Value Is Potentially 26% Above Its Share Price

Upcoming dividend of RM0.01 per share

Consensus EPS estimates increase by 30%

Price target increased to RM1.07

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Financial Year Ended December 31, 2022, Payable on December 28, 2022

KPJ Healthcare Berhad (KLSE:KPJ) Is Increasing Its Dividend To MYR0.0055

KPJ Healthcare Berhad Appoints Encik Hisham Bin Zainal Mokhtar as Independent and Non Executive Member of Risk Committee

KPJ Healthcare Berhad Announces Resignation of Mohd Shukrie Bin Mohd Salleh as Managing Director

KPJ Healthcare Berhad Announces Resignation of Mohd Shukrie Bin Mohd Salleh as Managing Director

KPJ Healthcare Berhad's (KLSE:KPJ) Shareholders Will Receive A Bigger Dividend Than Last Year

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Fiscal Year Ending December 31, 2022, Payable on 21 October 2022

KPJ Healthcare Berhad Announces the Resignation of TEH PENG PENG as Joint Secretary

KPJ Healthcare Berhad Appoints Nantha Kumar Subramanian as Its New Chief Digital Officer

KPJ Healthcare Berhad Appoints Lee Lai Fan as Independent and Non Executive Director

KPJ Healthcare Berhad Announces Retirement of Puan Lydia Anne Abraham as Independent and Non Executive Director

Consensus EPS estimates fall by 17%

High number of new directors

Now 22% undervalued after recent price drop

KPJ Healthcare Berhad Announces Single Tier Interim Dividend for the Financial Year Ending December 31, 2022, Payable on 29 Jul 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

KPJ Healthcare Berhad, Annual General Meeting, Jun 28, 2022